Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2F1 | ISIN: KYG9495L1251 | Ticker-Symbol:
NASDAQ
04.06.25 | 22:00
0,950 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VIRAX BIOLABS GROUP LIMITED Chart 1 Jahr
5-Tage-Chart
VIRAX BIOLABS GROUP LIMITED 5-Tage-Chart

Aktuelle News zur VIRAX BIOLABS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.03.Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating5
VIRAX BIOLABS GROUP Aktie jetzt für 0€ handeln
18.03.Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes91LONDON, March 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on...
► Artikel lesen
18.03.Virax Biolabs begins UK clinical study on T cell dysfunction1
13.03.Virax Biolabs Presents Findings On T-Cell Dysfunction In Post-Acute Infection Syndromes1
13.03.Virax Biolabs Group Ltd - 6-K, Report of foreign issuer1
13.03.Virax Biolabs shares T-Cell dysfunction findings2
05.03.Virax Biolabs Group Ltd - 6-K, Report of foreign issuer-
25.02.EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency4
25.02.Virax Biolabs Group Ltd - 6-K, Report of foreign issuer-
30.01.Virax Biolabs Group Ltd - S-8, Securities to be offered to employees in employee benefit plans-
23.01.Cosmos Health Inc.: Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait502CHICAGO, IL / ACCESS Newswire / January 23, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
13.01.Cosmos Health announces distribution agreement with Virax Biolabs3
13.01.Cosmos Health Inc.: Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries354CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
17.12.24Virax Biolabs Group Ltd - 6-K, Report of foreign issuer-
10.12.24Virax Biolabs Group Ltd - 6-K, Report of foreign issuer-
23.09.24Cosmos Health Inc: Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits234CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
16.09.24Cosmos Health Inc.: Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar275CHICAGO, IL / ACCESSWIRE / September 16, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...
► Artikel lesen
28.08.24Pre-market Movers: Bolt Projects, Acri Capital Acquisition, JBDI, Virax Biolabs, Ambarella1.002SAINT PAUL (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.50 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over...
► Artikel lesen
21.08.24Cosmos Health Inc.: Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox Virus Real-Time PCR Detection Kits487CHICAGO, IL / ACCESSWIRE / August 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D...
► Artikel lesen
07.06.24Pre-market Movers: Venus Concept, Versus Systems, Biomea Fusion, GameStop, Virax Biolabs808OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green Venus Concept Inc. (VERO) is up over 106% at $1.28. Versus...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1